// App-Quantinova.ai

1864 : In vivo efficacy of the PAK4 allosteric modulator KPT-9274 against a triple-negative breast cancer model

Researchers

Presenter

  • Chetan Rane

Principal Investigators

  • William Senapedis

  • Erkan Baloglu

  • Sharon Shacham

  • Audrey G. Minden

Medical Centers

  • Rutgers University, Piscataway, NJ.

  • Karyopharm Therapeutics, Newton, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved